XML 71 R57.htm IDEA: XBRL DOCUMENT v3.22.4
Equity Incentive Plans (Summary Of Restricted Share Unit Activity) (Details)
$ / shares in Units, $ in Thousands
12 Months Ended
Dec. 31, 2022
USD ($)
$ / shares
shares
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested [Roll Forward]  
Number of Shares, Outstanding at December 31, 2020 | shares 478,554
Number of Shares, Granted | shares 243,286
Number of Shares, Vested | shares (215,752)
Number of Shares, Outstanding at December 31, 2021 | shares 503,912
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]  
Weighted Average Grant Date Fair Value, Outstanding at December 31, 2020 | $ / shares $ 56.57
Weighted Average Grant Date Fair Value, Granted | $ / shares 46.65
Weighted Average Grant Date Fair Value, Vested | $ / shares 59.94
Weighted Average Grant Date Fair Value, Outstanding at December 31, 2021 | $ / shares $ 50.38
Weighted Average Life Remaining, Outstanding at December 31, 2021 10 months 9 days
Restricted Stock Units (RSUs) [Member]  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested [Roll Forward]  
Number of Shares, Outstanding at December 31, 2020 | shares 43,306
Number of Shares, Granted | shares 41,399
Number of Shares, Vested | shares (46,100)
Number of Shares, Outstanding at December 31, 2021 | shares 38,605
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]  
Weighted Average Grant Date Fair Value, Outstanding at December 31, 2020 | $ / shares $ 49.15
Weighted Average Grant Date Fair Value, Granted | $ / shares 50.49
Weighted Average Grant Date Fair Value, Vested | $ / shares 49.00
Weighted Average Grant Date Fair Value, Outstanding at December 31, 2021 | $ / shares $ 50.77
Weighted Average Life Remaining, Outstanding at December 31, 2021 5 months 1 day
Unamortized share-based compensation expense | $ $ 817